nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—UGT2B7—Epirubicin—uterine cancer	0.186	0.313	CbGbCtD
Flurbiprofen—UGT1A1—Etoposide—uterine cancer	0.125	0.211	CbGbCtD
Flurbiprofen—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0865	0.145	CbGbCtD
Flurbiprofen—PTGS2—Etoposide—uterine cancer	0.0754	0.127	CbGbCtD
Flurbiprofen—PTGS1—Etoposide—uterine cancer	0.0637	0.107	CbGbCtD
Flurbiprofen—CYP2C9—Progesterone—uterine cancer	0.0573	0.0963	CbGbCtD
Flurbiprofen—Mefenamic acid—AKR1C1—uterine cancer	0.00339	0.386	CrCbGaD
Flurbiprofen—PTGS1—oviduct—uterine cancer	0.00234	0.0868	CbGeAlD
Flurbiprofen—UGT1A9—renal system—uterine cancer	0.00207	0.0769	CbGeAlD
Flurbiprofen—Mefenamic acid—AKR1C3—uterine cancer	0.00197	0.224	CrCbGaD
Flurbiprofen—Naproxen—AKR1C3—uterine cancer	0.00193	0.22	CrCbGaD
Flurbiprofen—UGT2B7—renal system—uterine cancer	0.00167	0.062	CbGeAlD
Flurbiprofen—PTGS1—artery—uterine cancer	0.00155	0.0575	CbGeAlD
Flurbiprofen—PTGS2—artery—uterine cancer	0.00148	0.0549	CbGeAlD
Flurbiprofen—UGT1A1—renal system—uterine cancer	0.00142	0.0527	CbGeAlD
Flurbiprofen—UGT2B7—female reproductive system—uterine cancer	0.00134	0.0496	CbGeAlD
Flurbiprofen—ABCC4—renal system—uterine cancer	0.000924	0.0343	CbGeAlD
Flurbiprofen—ABCC4—uterus—uterine cancer	0.000824	0.0306	CbGeAlD
Flurbiprofen—Ketoprofen—CXCL8—uterine cancer	0.000753	0.0857	CrCbGaD
Flurbiprofen—Ibuprofen—CXCL8—uterine cancer	0.000741	0.0844	CrCbGaD
Flurbiprofen—ABCC4—female reproductive system—uterine cancer	0.00074	0.0275	CbGeAlD
Flurbiprofen—PTGS2—myometrium—uterine cancer	0.000715	0.0265	CbGeAlD
Flurbiprofen—ABCC4—female gonad—uterine cancer	0.000674	0.025	CbGeAlD
Flurbiprofen—PTGS1—epithelium—uterine cancer	0.000587	0.0218	CbGeAlD
Flurbiprofen—PTGS1—uterine cervix—uterine cancer	0.000582	0.0216	CbGeAlD
Flurbiprofen—PTGS1—smooth muscle tissue—uterine cancer	0.000565	0.021	CbGeAlD
Flurbiprofen—PTGS2—epithelium—uterine cancer	0.000561	0.0208	CbGeAlD
Flurbiprofen—PTGS2—uterine cervix—uterine cancer	0.000556	0.0207	CbGeAlD
Flurbiprofen—PTGS1—renal system—uterine cancer	0.000544	0.0202	CbGeAlD
Flurbiprofen—PTGS2—smooth muscle tissue—uterine cancer	0.00054	0.0201	CbGeAlD
Flurbiprofen—PTGS1—endometrium—uterine cancer	0.000526	0.0195	CbGeAlD
Flurbiprofen—PTGS2—renal system—uterine cancer	0.00052	0.0193	CbGeAlD
Flurbiprofen—PTGS1—mammalian vulva—uterine cancer	0.000509	0.0189	CbGeAlD
Flurbiprofen—PTGS2—endometrium—uterine cancer	0.000503	0.0187	CbGeAlD
Flurbiprofen—PTGS1—uterus—uterine cancer	0.000485	0.018	CbGeAlD
Flurbiprofen—CYP2C9—female reproductive system—uterine cancer	0.000477	0.0177	CbGeAlD
Flurbiprofen—PTGS2—uterus—uterine cancer	0.000463	0.0172	CbGeAlD
Flurbiprofen—ALB—lymph node—uterine cancer	0.000447	0.0166	CbGeAlD
Flurbiprofen—PTGS1—female reproductive system—uterine cancer	0.000436	0.0162	CbGeAlD
Flurbiprofen—ABCC4—lymph node—uterine cancer	0.000433	0.0161	CbGeAlD
Flurbiprofen—PTGS2—female reproductive system—uterine cancer	0.000417	0.0155	CbGeAlD
Flurbiprofen—PTGS1—female gonad—uterine cancer	0.000397	0.0147	CbGeAlD
Flurbiprofen—PTGS1—vagina—uterine cancer	0.000394	0.0146	CbGeAlD
Flurbiprofen—PTGS2—female gonad—uterine cancer	0.000379	0.0141	CbGeAlD
Flurbiprofen—PTGS2—vagina—uterine cancer	0.000377	0.014	CbGeAlD
Flurbiprofen—Affect lability—Epirubicin—uterine cancer	0.00026	0.000837	CcSEcCtD
Flurbiprofen—Migraine—Epirubicin—uterine cancer	0.00026	0.000837	CcSEcCtD
Flurbiprofen—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000259	0.000834	CcSEcCtD
Flurbiprofen—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000259	0.000833	CcSEcCtD
Flurbiprofen—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000259	0.000832	CcSEcCtD
Flurbiprofen—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000257	0.000828	CcSEcCtD
Flurbiprofen—Renal impairment—Doxorubicin—uterine cancer	0.000257	0.000827	CcSEcCtD
Flurbiprofen—Malaise—Etoposide—uterine cancer	0.000256	0.000824	CcSEcCtD
Flurbiprofen—Vertigo—Etoposide—uterine cancer	0.000255	0.000821	CcSEcCtD
Flurbiprofen—PTGS1—lymph node—uterine cancer	0.000255	0.00947	CbGeAlD
Flurbiprofen—Leukopenia—Etoposide—uterine cancer	0.000254	0.000818	CcSEcCtD
Flurbiprofen—Purpura—Doxorubicin—uterine cancer	0.000254	0.000817	CcSEcCtD
Flurbiprofen—Abdominal pain—Dactinomycin—uterine cancer	0.000253	0.000815	CcSEcCtD
Flurbiprofen—Body temperature increased—Dactinomycin—uterine cancer	0.000253	0.000815	CcSEcCtD
Flurbiprofen—Mood swings—Epirubicin—uterine cancer	0.000251	0.000806	CcSEcCtD
Flurbiprofen—Loss of consciousness—Etoposide—uterine cancer	0.00025	0.000803	CcSEcCtD
Flurbiprofen—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00025	0.000803	CcSEcCtD
Flurbiprofen—Ataxia—Epirubicin—uterine cancer	0.000249	0.0008	CcSEcCtD
Flurbiprofen—Cough—Etoposide—uterine cancer	0.000248	0.000797	CcSEcCtD
Flurbiprofen—Convulsion—Etoposide—uterine cancer	0.000246	0.000792	CcSEcCtD
Flurbiprofen—Hypertension—Etoposide—uterine cancer	0.000245	0.000789	CcSEcCtD
Flurbiprofen—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000245	0.000787	CcSEcCtD
Flurbiprofen—Osteoarthritis—Doxorubicin—uterine cancer	0.000245	0.000787	CcSEcCtD
Flurbiprofen—Diplopia—Doxorubicin—uterine cancer	0.000245	0.000787	CcSEcCtD
Flurbiprofen—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000244	0.000785	CcSEcCtD
Flurbiprofen—PTGS2—lymph node—uterine cancer	0.000244	0.00905	CbGeAlD
Flurbiprofen—Dry skin—Epirubicin—uterine cancer	0.000243	0.00078	CcSEcCtD
Flurbiprofen—Affect lability—Doxorubicin—uterine cancer	0.000241	0.000775	CcSEcCtD
Flurbiprofen—Migraine—Doxorubicin—uterine cancer	0.000241	0.000775	CcSEcCtD
Flurbiprofen—Discomfort—Etoposide—uterine cancer	0.000239	0.000769	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000238	0.000766	CcSEcCtD
Flurbiprofen—Hypersensitivity—Dactinomycin—uterine cancer	0.000236	0.000759	CcSEcCtD
Flurbiprofen—Gastritis—Epirubicin—uterine cancer	0.000234	0.000753	CcSEcCtD
Flurbiprofen—Confusional state—Etoposide—uterine cancer	0.000234	0.000752	CcSEcCtD
Flurbiprofen—Muscular weakness—Epirubicin—uterine cancer	0.000233	0.00075	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Etoposide—uterine cancer	0.000232	0.000746	CcSEcCtD
Flurbiprofen—Mood swings—Doxorubicin—uterine cancer	0.000232	0.000746	CcSEcCtD
Flurbiprofen—Infection—Etoposide—uterine cancer	0.00023	0.000741	CcSEcCtD
Flurbiprofen—Abdominal distension—Epirubicin—uterine cancer	0.00023	0.00074	CcSEcCtD
Flurbiprofen—Ataxia—Doxorubicin—uterine cancer	0.00023	0.00074	CcSEcCtD
Flurbiprofen—Asthenia—Dactinomycin—uterine cancer	0.00023	0.000739	CcSEcCtD
Flurbiprofen—Influenza—Epirubicin—uterine cancer	0.000229	0.000735	CcSEcCtD
Flurbiprofen—Asthma—Epirubicin—uterine cancer	0.000229	0.000735	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Etoposide—uterine cancer	0.000227	0.00073	CcSEcCtD
Flurbiprofen—Tachycardia—Etoposide—uterine cancer	0.000226	0.000728	CcSEcCtD
Flurbiprofen—Eosinophilia—Epirubicin—uterine cancer	0.000226	0.000728	CcSEcCtD
Flurbiprofen—Dry skin—Doxorubicin—uterine cancer	0.000224	0.000721	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Etoposide—uterine cancer	0.000224	0.000721	CcSEcCtD
Flurbiprofen—Pancreatitis—Epirubicin—uterine cancer	0.000224	0.000721	CcSEcCtD
Flurbiprofen—Angina pectoris—Epirubicin—uterine cancer	0.000223	0.000716	CcSEcCtD
Flurbiprofen—Anorexia—Etoposide—uterine cancer	0.000221	0.000711	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00022	0.000709	CcSEcCtD
Flurbiprofen—Bronchitis—Epirubicin—uterine cancer	0.00022	0.000707	CcSEcCtD
Flurbiprofen—Diarrhoea—Dactinomycin—uterine cancer	0.000219	0.000705	CcSEcCtD
Flurbiprofen—Pancytopenia—Epirubicin—uterine cancer	0.000217	0.000698	CcSEcCtD
Flurbiprofen—Hypotension—Etoposide—uterine cancer	0.000217	0.000697	CcSEcCtD
Flurbiprofen—Gastritis—Doxorubicin—uterine cancer	0.000217	0.000697	CcSEcCtD
Flurbiprofen—Muscular weakness—Doxorubicin—uterine cancer	0.000216	0.000694	CcSEcCtD
Flurbiprofen—Dysuria—Epirubicin—uterine cancer	0.000214	0.000687	CcSEcCtD
Flurbiprofen—Neutropenia—Epirubicin—uterine cancer	0.000214	0.000687	CcSEcCtD
Flurbiprofen—Abdominal distension—Doxorubicin—uterine cancer	0.000213	0.000685	CcSEcCtD
Flurbiprofen—Influenza—Doxorubicin—uterine cancer	0.000212	0.00068	CcSEcCtD
Flurbiprofen—Asthma—Doxorubicin—uterine cancer	0.000212	0.00068	CcSEcCtD
Flurbiprofen—Eosinophilia—Doxorubicin—uterine cancer	0.000209	0.000674	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Epirubicin—uterine cancer	0.000209	0.000671	CcSEcCtD
Flurbiprofen—Paraesthesia—Etoposide—uterine cancer	0.000208	0.00067	CcSEcCtD
Flurbiprofen—Pancreatitis—Doxorubicin—uterine cancer	0.000207	0.000667	CcSEcCtD
Flurbiprofen—Dyspnoea—Etoposide—uterine cancer	0.000207	0.000665	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Epirubicin—uterine cancer	0.000206	0.000663	CcSEcCtD
Flurbiprofen—Somnolence—Etoposide—uterine cancer	0.000206	0.000663	CcSEcCtD
Flurbiprofen—Angina pectoris—Doxorubicin—uterine cancer	0.000206	0.000663	CcSEcCtD
Flurbiprofen—Pneumonia—Epirubicin—uterine cancer	0.000205	0.000659	CcSEcCtD
Flurbiprofen—Drowsiness—Epirubicin—uterine cancer	0.000204	0.000656	CcSEcCtD
Flurbiprofen—Vomiting—Dactinomycin—uterine cancer	0.000204	0.000655	CcSEcCtD
Flurbiprofen—Bronchitis—Doxorubicin—uterine cancer	0.000203	0.000654	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000202	0.00065	CcSEcCtD
Flurbiprofen—Rash—Dactinomycin—uterine cancer	0.000202	0.00065	CcSEcCtD
Flurbiprofen—Decreased appetite—Etoposide—uterine cancer	0.000202	0.000648	CcSEcCtD
Flurbiprofen—Pancytopenia—Doxorubicin—uterine cancer	0.000201	0.000646	CcSEcCtD
Flurbiprofen—Renal failure—Epirubicin—uterine cancer	0.0002	0.000644	CcSEcCtD
Flurbiprofen—Jaundice—Epirubicin—uterine cancer	0.000199	0.000639	CcSEcCtD
Flurbiprofen—Stomatitis—Epirubicin—uterine cancer	0.000199	0.000639	CcSEcCtD
Flurbiprofen—Pain—Etoposide—uterine cancer	0.000198	0.000638	CcSEcCtD
Flurbiprofen—Constipation—Etoposide—uterine cancer	0.000198	0.000638	CcSEcCtD
Flurbiprofen—Urinary tract infection—Epirubicin—uterine cancer	0.000198	0.000637	CcSEcCtD
Flurbiprofen—Conjunctivitis—Epirubicin—uterine cancer	0.000198	0.000637	CcSEcCtD
Flurbiprofen—Dysuria—Doxorubicin—uterine cancer	0.000198	0.000636	CcSEcCtD
Flurbiprofen—Neutropenia—Doxorubicin—uterine cancer	0.000198	0.000636	CcSEcCtD
Flurbiprofen—Sweating—Epirubicin—uterine cancer	0.000195	0.000628	CcSEcCtD
Flurbiprofen—Haematuria—Epirubicin—uterine cancer	0.000194	0.000625	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000193	0.000621	CcSEcCtD
Flurbiprofen—Epistaxis—Epirubicin—uterine cancer	0.000192	0.000618	CcSEcCtD
Flurbiprofen—Sinusitis—Epirubicin—uterine cancer	0.000191	0.000615	CcSEcCtD
Flurbiprofen—Feeling abnormal—Etoposide—uterine cancer	0.000191	0.000615	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Doxorubicin—uterine cancer	0.000191	0.000614	CcSEcCtD
Flurbiprofen—Nausea—Dactinomycin—uterine cancer	0.00019	0.000612	CcSEcCtD
Flurbiprofen—Agranulocytosis—Epirubicin—uterine cancer	0.00019	0.000612	CcSEcCtD
Flurbiprofen—Pneumonia—Doxorubicin—uterine cancer	0.00019	0.00061	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Etoposide—uterine cancer	0.00019	0.00061	CcSEcCtD
Flurbiprofen—Drowsiness—Doxorubicin—uterine cancer	0.000189	0.000607	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000187	0.000601	CcSEcCtD
Flurbiprofen—Renal failure—Doxorubicin—uterine cancer	0.000185	0.000596	CcSEcCtD
Flurbiprofen—Urticaria—Etoposide—uterine cancer	0.000184	0.000592	CcSEcCtD
Flurbiprofen—Haemoglobin—Epirubicin—uterine cancer	0.000184	0.000591	CcSEcCtD
Flurbiprofen—Jaundice—Doxorubicin—uterine cancer	0.000184	0.000591	CcSEcCtD
Flurbiprofen—Stomatitis—Doxorubicin—uterine cancer	0.000184	0.000591	CcSEcCtD
Flurbiprofen—Rhinitis—Epirubicin—uterine cancer	0.000183	0.00059	CcSEcCtD
Flurbiprofen—Abdominal pain—Etoposide—uterine cancer	0.000183	0.00059	CcSEcCtD
Flurbiprofen—Body temperature increased—Etoposide—uterine cancer	0.000183	0.00059	CcSEcCtD
Flurbiprofen—Urinary tract infection—Doxorubicin—uterine cancer	0.000183	0.00059	CcSEcCtD
Flurbiprofen—Conjunctivitis—Doxorubicin—uterine cancer	0.000183	0.00059	CcSEcCtD
Flurbiprofen—Haemorrhage—Epirubicin—uterine cancer	0.000183	0.000588	CcSEcCtD
Flurbiprofen—Hepatitis—Epirubicin—uterine cancer	0.000183	0.000588	CcSEcCtD
Flurbiprofen—Pharyngitis—Epirubicin—uterine cancer	0.000182	0.000584	CcSEcCtD
Flurbiprofen—Sweating—Doxorubicin—uterine cancer	0.000181	0.000581	CcSEcCtD
Flurbiprofen—Haematuria—Doxorubicin—uterine cancer	0.00018	0.000578	CcSEcCtD
Flurbiprofen—Epistaxis—Doxorubicin—uterine cancer	0.000178	0.000572	CcSEcCtD
Flurbiprofen—Sinusitis—Doxorubicin—uterine cancer	0.000177	0.000569	CcSEcCtD
Flurbiprofen—Visual impairment—Epirubicin—uterine cancer	0.000176	0.000567	CcSEcCtD
Flurbiprofen—Agranulocytosis—Doxorubicin—uterine cancer	0.000176	0.000566	CcSEcCtD
Flurbiprofen—Erythema multiforme—Epirubicin—uterine cancer	0.000173	0.000556	CcSEcCtD
Flurbiprofen—Hypersensitivity—Etoposide—uterine cancer	0.000171	0.000549	CcSEcCtD
Flurbiprofen—Tinnitus—Epirubicin—uterine cancer	0.000171	0.000549	CcSEcCtD
Flurbiprofen—Haemoglobin—Doxorubicin—uterine cancer	0.00017	0.000547	CcSEcCtD
Flurbiprofen—Rhinitis—Doxorubicin—uterine cancer	0.00017	0.000546	CcSEcCtD
Flurbiprofen—Haemorrhage—Doxorubicin—uterine cancer	0.000169	0.000544	CcSEcCtD
Flurbiprofen—Hepatitis—Doxorubicin—uterine cancer	0.000169	0.000544	CcSEcCtD
Flurbiprofen—Pharyngitis—Doxorubicin—uterine cancer	0.000168	0.00054	CcSEcCtD
Flurbiprofen—Asthenia—Etoposide—uterine cancer	0.000166	0.000535	CcSEcCtD
Flurbiprofen—Angiopathy—Epirubicin—uterine cancer	0.000166	0.000534	CcSEcCtD
Flurbiprofen—Chills—Epirubicin—uterine cancer	0.000164	0.000528	CcSEcCtD
Flurbiprofen—Pruritus—Etoposide—uterine cancer	0.000164	0.000528	CcSEcCtD
Flurbiprofen—Arrhythmia—Epirubicin—uterine cancer	0.000164	0.000526	CcSEcCtD
Flurbiprofen—Visual impairment—Doxorubicin—uterine cancer	0.000163	0.000525	CcSEcCtD
Flurbiprofen—Alopecia—Epirubicin—uterine cancer	0.000162	0.00052	CcSEcCtD
Flurbiprofen—Erythema multiforme—Doxorubicin—uterine cancer	0.00016	0.000515	CcSEcCtD
Flurbiprofen—Diarrhoea—Etoposide—uterine cancer	0.000159	0.00051	CcSEcCtD
Flurbiprofen—Tinnitus—Doxorubicin—uterine cancer	0.000158	0.000508	CcSEcCtD
Flurbiprofen—Flatulence—Epirubicin—uterine cancer	0.000157	0.000505	CcSEcCtD
Flurbiprofen—Tension—Epirubicin—uterine cancer	0.000156	0.000503	CcSEcCtD
Flurbiprofen—Nervousness—Epirubicin—uterine cancer	0.000155	0.000498	CcSEcCtD
Flurbiprofen—Angiopathy—Doxorubicin—uterine cancer	0.000154	0.000494	CcSEcCtD
Flurbiprofen—Dizziness—Etoposide—uterine cancer	0.000153	0.000493	CcSEcCtD
Flurbiprofen—Chills—Doxorubicin—uterine cancer	0.000152	0.000489	CcSEcCtD
Flurbiprofen—Arrhythmia—Doxorubicin—uterine cancer	0.000151	0.000486	CcSEcCtD
Flurbiprofen—Alopecia—Doxorubicin—uterine cancer	0.00015	0.000481	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Epirubicin—uterine cancer	0.000148	0.000475	CcSEcCtD
Flurbiprofen—Vomiting—Etoposide—uterine cancer	0.000147	0.000474	CcSEcCtD
Flurbiprofen—Anaemia—Epirubicin—uterine cancer	0.000147	0.000473	CcSEcCtD
Flurbiprofen—Rash—Etoposide—uterine cancer	0.000146	0.00047	CcSEcCtD
Flurbiprofen—Dermatitis—Etoposide—uterine cancer	0.000146	0.00047	CcSEcCtD
Flurbiprofen—Headache—Etoposide—uterine cancer	0.000145	0.000467	CcSEcCtD
Flurbiprofen—Flatulence—Doxorubicin—uterine cancer	0.000145	0.000467	CcSEcCtD
Flurbiprofen—Tension—Doxorubicin—uterine cancer	0.000145	0.000465	CcSEcCtD
Flurbiprofen—Malaise—Epirubicin—uterine cancer	0.000144	0.000462	CcSEcCtD
Flurbiprofen—Nervousness—Doxorubicin—uterine cancer	0.000143	0.00046	CcSEcCtD
Flurbiprofen—Vertigo—Epirubicin—uterine cancer	0.000143	0.00046	CcSEcCtD
Flurbiprofen—Syncope—Epirubicin—uterine cancer	0.000143	0.000459	CcSEcCtD
Flurbiprofen—Leukopenia—Epirubicin—uterine cancer	0.000143	0.000459	CcSEcCtD
Flurbiprofen—Palpitations—Epirubicin—uterine cancer	0.000141	0.000453	CcSEcCtD
Flurbiprofen—Loss of consciousness—Epirubicin—uterine cancer	0.00014	0.00045	CcSEcCtD
Flurbiprofen—Cough—Epirubicin—uterine cancer	0.000139	0.000447	CcSEcCtD
Flurbiprofen—Convulsion—Epirubicin—uterine cancer	0.000138	0.000444	CcSEcCtD
Flurbiprofen—Nausea—Etoposide—uterine cancer	0.000138	0.000443	CcSEcCtD
Flurbiprofen—Hypertension—Epirubicin—uterine cancer	0.000138	0.000442	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Doxorubicin—uterine cancer	0.000137	0.00044	CcSEcCtD
Flurbiprofen—Anaemia—Doxorubicin—uterine cancer	0.000136	0.000438	CcSEcCtD
Flurbiprofen—Myalgia—Epirubicin—uterine cancer	0.000136	0.000436	CcSEcCtD
Flurbiprofen—Anxiety—Epirubicin—uterine cancer	0.000135	0.000435	CcSEcCtD
Flurbiprofen—Discomfort—Epirubicin—uterine cancer	0.000134	0.000431	CcSEcCtD
Flurbiprofen—Malaise—Doxorubicin—uterine cancer	0.000133	0.000427	CcSEcCtD
Flurbiprofen—Dry mouth—Epirubicin—uterine cancer	0.000133	0.000427	CcSEcCtD
Flurbiprofen—Vertigo—Doxorubicin—uterine cancer	0.000132	0.000426	CcSEcCtD
Flurbiprofen—Syncope—Doxorubicin—uterine cancer	0.000132	0.000425	CcSEcCtD
Flurbiprofen—Leukopenia—Doxorubicin—uterine cancer	0.000132	0.000424	CcSEcCtD
Flurbiprofen—Confusional state—Epirubicin—uterine cancer	0.000131	0.000422	CcSEcCtD
Flurbiprofen—Palpitations—Doxorubicin—uterine cancer	0.00013	0.000419	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Epirubicin—uterine cancer	0.00013	0.000418	CcSEcCtD
Flurbiprofen—Oedema—Epirubicin—uterine cancer	0.00013	0.000418	CcSEcCtD
Flurbiprofen—Loss of consciousness—Doxorubicin—uterine cancer	0.00013	0.000417	CcSEcCtD
Flurbiprofen—Infection—Epirubicin—uterine cancer	0.000129	0.000415	CcSEcCtD
Flurbiprofen—Cough—Doxorubicin—uterine cancer	0.000129	0.000414	CcSEcCtD
Flurbiprofen—Shock—Epirubicin—uterine cancer	0.000128	0.000411	CcSEcCtD
Flurbiprofen—Convulsion—Doxorubicin—uterine cancer	0.000128	0.000411	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Epirubicin—uterine cancer	0.000127	0.000409	CcSEcCtD
Flurbiprofen—Hypertension—Doxorubicin—uterine cancer	0.000127	0.000409	CcSEcCtD
Flurbiprofen—Tachycardia—Epirubicin—uterine cancer	0.000127	0.000408	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Epirubicin—uterine cancer	0.000126	0.000404	CcSEcCtD
Flurbiprofen—Myalgia—Doxorubicin—uterine cancer	0.000126	0.000404	CcSEcCtD
Flurbiprofen—Anxiety—Doxorubicin—uterine cancer	0.000125	0.000402	CcSEcCtD
Flurbiprofen—Discomfort—Doxorubicin—uterine cancer	0.000124	0.000399	CcSEcCtD
Flurbiprofen—Anorexia—Epirubicin—uterine cancer	0.000124	0.000399	CcSEcCtD
Flurbiprofen—Dry mouth—Doxorubicin—uterine cancer	0.000123	0.000395	CcSEcCtD
Flurbiprofen—Hypotension—Epirubicin—uterine cancer	0.000122	0.000391	CcSEcCtD
Flurbiprofen—Confusional state—Doxorubicin—uterine cancer	0.000121	0.00039	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Doxorubicin—uterine cancer	0.00012	0.000387	CcSEcCtD
Flurbiprofen—Oedema—Doxorubicin—uterine cancer	0.00012	0.000387	CcSEcCtD
Flurbiprofen—Infection—Doxorubicin—uterine cancer	0.00012	0.000384	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000118	0.000381	CcSEcCtD
Flurbiprofen—Shock—Doxorubicin—uterine cancer	0.000118	0.000381	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Doxorubicin—uterine cancer	0.000118	0.000379	CcSEcCtD
Flurbiprofen—Insomnia—Epirubicin—uterine cancer	0.000118	0.000378	CcSEcCtD
Flurbiprofen—Tachycardia—Doxorubicin—uterine cancer	0.000117	0.000378	CcSEcCtD
Flurbiprofen—Paraesthesia—Epirubicin—uterine cancer	0.000117	0.000375	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Doxorubicin—uterine cancer	0.000116	0.000374	CcSEcCtD
Flurbiprofen—Dyspnoea—Epirubicin—uterine cancer	0.000116	0.000373	CcSEcCtD
Flurbiprofen—Somnolence—Epirubicin—uterine cancer	0.000116	0.000372	CcSEcCtD
Flurbiprofen—Anorexia—Doxorubicin—uterine cancer	0.000115	0.000369	CcSEcCtD
Flurbiprofen—Dyspepsia—Epirubicin—uterine cancer	0.000114	0.000368	CcSEcCtD
Flurbiprofen—Decreased appetite—Epirubicin—uterine cancer	0.000113	0.000363	CcSEcCtD
Flurbiprofen—Hypotension—Doxorubicin—uterine cancer	0.000112	0.000361	CcSEcCtD
Flurbiprofen—Pain—Epirubicin—uterine cancer	0.000111	0.000358	CcSEcCtD
Flurbiprofen—Constipation—Epirubicin—uterine cancer	0.000111	0.000358	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00011	0.000352	CcSEcCtD
Flurbiprofen—Insomnia—Doxorubicin—uterine cancer	0.000109	0.00035	CcSEcCtD
Flurbiprofen—Paraesthesia—Doxorubicin—uterine cancer	0.000108	0.000347	CcSEcCtD
Flurbiprofen—Dyspnoea—Doxorubicin—uterine cancer	0.000107	0.000345	CcSEcCtD
Flurbiprofen—Feeling abnormal—Epirubicin—uterine cancer	0.000107	0.000345	CcSEcCtD
Flurbiprofen—Somnolence—Doxorubicin—uterine cancer	0.000107	0.000344	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Epirubicin—uterine cancer	0.000106	0.000342	CcSEcCtD
Flurbiprofen—Dyspepsia—Doxorubicin—uterine cancer	0.000106	0.000341	CcSEcCtD
Flurbiprofen—Decreased appetite—Doxorubicin—uterine cancer	0.000105	0.000336	CcSEcCtD
Flurbiprofen—Urticaria—Epirubicin—uterine cancer	0.000103	0.000332	CcSEcCtD
Flurbiprofen—Pain—Doxorubicin—uterine cancer	0.000103	0.000331	CcSEcCtD
Flurbiprofen—Constipation—Doxorubicin—uterine cancer	0.000103	0.000331	CcSEcCtD
Flurbiprofen—Body temperature increased—Epirubicin—uterine cancer	0.000103	0.00033	CcSEcCtD
Flurbiprofen—Abdominal pain—Epirubicin—uterine cancer	0.000103	0.00033	CcSEcCtD
Flurbiprofen—Feeling abnormal—Doxorubicin—uterine cancer	9.92e-05	0.000319	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Doxorubicin—uterine cancer	9.84e-05	0.000316	CcSEcCtD
Flurbiprofen—Hypersensitivity—Epirubicin—uterine cancer	9.58e-05	0.000308	CcSEcCtD
Flurbiprofen—Urticaria—Doxorubicin—uterine cancer	9.56e-05	0.000307	CcSEcCtD
Flurbiprofen—Abdominal pain—Doxorubicin—uterine cancer	9.51e-05	0.000306	CcSEcCtD
Flurbiprofen—Body temperature increased—Doxorubicin—uterine cancer	9.51e-05	0.000306	CcSEcCtD
Flurbiprofen—Asthenia—Epirubicin—uterine cancer	9.33e-05	0.0003	CcSEcCtD
Flurbiprofen—Pruritus—Epirubicin—uterine cancer	9.2e-05	0.000296	CcSEcCtD
Flurbiprofen—UGT1A1—Metabolism—SRD5A2—uterine cancer	9.19e-05	0.00156	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—NDUFB11—uterine cancer	9.19e-05	0.00156	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—SRD5A2—uterine cancer	9.19e-05	0.00156	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	9.13e-05	0.00155	CbGpPWpGaD
Flurbiprofen—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	9e-05	0.00153	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.93e-05	0.00152	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	8.93e-05	0.00152	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—CDKN1B—uterine cancer	8.92e-05	0.00152	CbGpPWpGaD
Flurbiprofen—Diarrhoea—Epirubicin—uterine cancer	8.9e-05	0.000286	CcSEcCtD
Flurbiprofen—Hypersensitivity—Doxorubicin—uterine cancer	8.86e-05	0.000285	CcSEcCtD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.85e-05	0.00151	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—CCL2—uterine cancer	8.8e-05	0.0015	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	8.68e-05	0.00148	CbGpPWpGaD
Flurbiprofen—Asthenia—Doxorubicin—uterine cancer	8.63e-05	0.000278	CcSEcCtD
Flurbiprofen—Dizziness—Epirubicin—uterine cancer	8.6e-05	0.000276	CcSEcCtD
Flurbiprofen—Pruritus—Doxorubicin—uterine cancer	8.51e-05	0.000274	CcSEcCtD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	8.43e-05	0.00144	CbGpPWpGaD
Flurbiprofen—Vomiting—Epirubicin—uterine cancer	8.27e-05	0.000266	CcSEcCtD
Flurbiprofen—Diarrhoea—Doxorubicin—uterine cancer	8.23e-05	0.000265	CcSEcCtD
Flurbiprofen—Rash—Epirubicin—uterine cancer	8.2e-05	0.000264	CcSEcCtD
Flurbiprofen—Dermatitis—Epirubicin—uterine cancer	8.19e-05	0.000263	CcSEcCtD
Flurbiprofen—UGT2B7—Metabolism—AKR1B1—uterine cancer	8.18e-05	0.00139	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—STAR—uterine cancer	8.18e-05	0.00139	CbGpPWpGaD
Flurbiprofen—Headache—Epirubicin—uterine cancer	8.15e-05	0.000262	CcSEcCtD
Flurbiprofen—Dizziness—Doxorubicin—uterine cancer	7.96e-05	0.000256	CcSEcCtD
Flurbiprofen—UGT2B4—Metabolism—STK11—uterine cancer	7.9e-05	0.00135	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—CYP19A1—uterine cancer	7.9e-05	0.00135	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—EP300—uterine cancer	7.83e-05	0.00133	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.81e-05	0.00133	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.81e-05	0.00133	CbGpPWpGaD
Flurbiprofen—Nausea—Epirubicin—uterine cancer	7.72e-05	0.000248	CcSEcCtD
Flurbiprofen—Vomiting—Doxorubicin—uterine cancer	7.65e-05	0.000246	CcSEcCtD
Flurbiprofen—Rash—Doxorubicin—uterine cancer	7.59e-05	0.000244	CcSEcCtD
Flurbiprofen—Dermatitis—Doxorubicin—uterine cancer	7.58e-05	0.000244	CcSEcCtD
Flurbiprofen—UGT1A3—Metabolism—POLD1—uterine cancer	7.55e-05	0.00128	CbGpPWpGaD
Flurbiprofen—Headache—Doxorubicin—uterine cancer	7.54e-05	0.000242	CcSEcCtD
Flurbiprofen—PTGS1—Metabolism—SRD5A2—uterine cancer	7.49e-05	0.00128	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—NDUFB11—uterine cancer	7.49e-05	0.00128	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	7.43e-05	0.00126	CbGpPWpGaD
Flurbiprofen—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	7.33e-05	0.00125	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—NRAS—uterine cancer	7.33e-05	0.00125	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.28e-05	0.00124	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	7.23e-05	0.00123	CbGpPWpGaD
Flurbiprofen—Nausea—Doxorubicin—uterine cancer	7.15e-05	0.00023	CcSEcCtD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	7.09e-05	0.00121	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—AKR1C1—uterine cancer	7.06e-05	0.0012	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—CXCL8—uterine cancer	6.96e-05	0.00118	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.87e-05	0.00117	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	6.8e-05	0.00116	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—CDKN1B—uterine cancer	6.79e-05	0.00116	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—STAR—uterine cancer	6.65e-05	0.00113	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—AKR1B1—uterine cancer	6.65e-05	0.00113	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—AKR1B1—uterine cancer	6.65e-05	0.00113	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—STAR—uterine cancer	6.65e-05	0.00113	CbGpPWpGaD
Flurbiprofen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	6.58e-05	0.00112	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.57e-05	0.00112	CbGpPWpGaD
Flurbiprofen—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	6.42e-05	0.00109	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—POLD1—uterine cancer	6.42e-05	0.00109	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.39e-05	0.00109	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.39e-05	0.00109	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	6.3e-05	0.00107	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—RRM2—uterine cancer	6.29e-05	0.00107	CbGpPWpGaD
Flurbiprofen—ALB—Platelet degranulation—VEGFA—uterine cancer	6.24e-05	0.00106	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	6.12e-05	0.00104	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—DCN—uterine cancer	6.11e-05	0.00104	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—AKR1C1—uterine cancer	6e-05	0.00102	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—SRD5A2—uterine cancer	5.95e-05	0.00101	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NDUFB11—uterine cancer	5.95e-05	0.00101	CbGpPWpGaD
Flurbiprofen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	5.94e-05	0.00101	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—MTHFR—uterine cancer	5.94e-05	0.00101	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.78e-05	0.000983	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—CYP11A1—uterine cancer	5.75e-05	0.000979	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.73e-05	0.000976	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—AKR1B10—uterine cancer	5.52e-05	0.00094	CbGpPWpGaD
Flurbiprofen—ALB—Folate Metabolism—TP53—uterine cancer	5.5e-05	0.000936	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.46e-05	0.000929	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—AKR1C3—uterine cancer	5.43e-05	0.000925	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—STAR—uterine cancer	5.42e-05	0.000922	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—AKR1B1—uterine cancer	5.42e-05	0.000922	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	5.36e-05	0.000912	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.35e-05	0.000911	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—RRM2—uterine cancer	5.35e-05	0.000911	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—POLD1—uterine cancer	5.21e-05	0.000888	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—POLD1—uterine cancer	5.21e-05	0.000888	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—DCN—uterine cancer	5.19e-05	0.000884	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	4.99e-05	0.000849	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CYP11A1—uterine cancer	4.89e-05	0.000833	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—AKR1C1—uterine cancer	4.88e-05	0.00083	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—AKR1C1—uterine cancer	4.88e-05	0.00083	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—IRF1—uterine cancer	4.82e-05	0.000821	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—SRD5A2—uterine cancer	4.81e-05	0.000819	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NDUFB11—uterine cancer	4.81e-05	0.000819	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	4.78e-05	0.000813	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.69e-05	0.000799	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.67e-05	0.000796	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	4.62e-05	0.000787	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—AKR1C3—uterine cancer	4.62e-05	0.000787	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—RNF43—uterine cancer	4.58e-05	0.000779	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.41e-05	0.000751	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	4.37e-05	0.000743	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—RRM2—uterine cancer	4.35e-05	0.00074	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—RRM2—uterine cancer	4.35e-05	0.00074	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—STAR—uterine cancer	4.3e-05	0.000732	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—AKR1B1—uterine cancer	4.3e-05	0.000732	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—TP53—uterine cancer	4.27e-05	0.000727	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.26e-05	0.000724	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—POLD1—uterine cancer	4.25e-05	0.000724	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.25e-05	0.000724	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—STK11—uterine cancer	4.23e-05	0.000721	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—CYP19A1—uterine cancer	4.23e-05	0.000721	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—DCN—uterine cancer	4.22e-05	0.000718	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—DCN—uterine cancer	4.22e-05	0.000718	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4.06e-05	0.000691	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CYP11A1—uterine cancer	3.98e-05	0.000677	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CYP11A1—uterine cancer	3.98e-05	0.000677	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—AKR1C1—uterine cancer	3.98e-05	0.000677	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—SRD5A2—uterine cancer	3.94e-05	0.00067	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NDUFB11—uterine cancer	3.94e-05	0.00067	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	3.9e-05	0.000664	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	3.84e-05	0.000654	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.83e-05	0.000651	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—AKR1C1—uterine cancer	3.77e-05	0.000642	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—AKR1C3—uterine cancer	3.76e-05	0.000639	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—AKR1C3—uterine cancer	3.76e-05	0.000639	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.61e-05	0.000615	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CYP19A1—uterine cancer	3.6e-05	0.000613	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—STK11—uterine cancer	3.6e-05	0.000613	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—RRM2—uterine cancer	3.54e-05	0.000603	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—STAR—uterine cancer	3.48e-05	0.000592	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—AKR1B1—uterine cancer	3.48e-05	0.000592	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—DCN—uterine cancer	3.44e-05	0.000586	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.44e-05	0.000585	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—POLD1—uterine cancer	3.37e-05	0.000574	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—EP300—uterine cancer	3.33e-05	0.000566	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PTEN—uterine cancer	3.3e-05	0.000562	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.27e-05	0.000556	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—DCN—uterine cancer	3.26e-05	0.000555	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CYP11A1—uterine cancer	3.24e-05	0.000552	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—MTHFR—uterine cancer	3.18e-05	0.000542	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—AKR1C1—uterine cancer	3.16e-05	0.000537	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—VEGFA—uterine cancer	3.15e-05	0.000537	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—EP300—uterine cancer	3.15e-05	0.000536	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—NRAS—uterine cancer	3.11e-05	0.00053	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—AKR1C3—uterine cancer	3.06e-05	0.000521	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3e-05	0.000511	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—STK11—uterine cancer	2.93e-05	0.000498	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CYP19A1—uterine cancer	2.93e-05	0.000498	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—STK11—uterine cancer	2.93e-05	0.000498	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CYP19A1—uterine cancer	2.93e-05	0.000498	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.9e-05	0.000494	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—AKR1C3—uterine cancer	2.9e-05	0.000494	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—STAR—uterine cancer	2.85e-05	0.000485	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AKR1B1—uterine cancer	2.85e-05	0.000485	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HMGA1—uterine cancer	2.83e-05	0.000481	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.82e-05	0.000479	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—RRM2—uterine cancer	2.81e-05	0.000479	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	2.77e-05	0.000471	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.75e-05	0.000467	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—DCN—uterine cancer	2.73e-05	0.000465	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—POLD1—uterine cancer	2.73e-05	0.000465	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—MTHFR—uterine cancer	2.71e-05	0.00046	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—KRAS—uterine cancer	2.68e-05	0.000456	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.62e-05	0.000446	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FBXW7—uterine cancer	2.59e-05	0.00044	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYP11A1—uterine cancer	2.57e-05	0.000438	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—AKR1C1—uterine cancer	2.55e-05	0.000435	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—PIK3CA—uterine cancer	2.46e-05	0.000419	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.45e-05	0.000417	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—AKR1C3—uterine cancer	2.43e-05	0.000414	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—STK11—uterine cancer	2.38e-05	0.000406	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CYP19A1—uterine cancer	2.38e-05	0.000406	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—TP53—uterine cancer	2.38e-05	0.000405	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PIK3CA—uterine cancer	2.33e-05	0.000397	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—HRAS—uterine cancer	2.28e-05	0.000388	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—RRM2—uterine cancer	2.28e-05	0.000387	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.24e-05	0.000381	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—POLD1—uterine cancer	2.23e-05	0.00038	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—DCN—uterine cancer	2.21e-05	0.000376	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—MTHFR—uterine cancer	2.2e-05	0.000374	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—MTHFR—uterine cancer	2.2e-05	0.000374	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	2.16e-05	0.000368	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.13e-05	0.000363	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.09e-05	0.000356	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP11A1—uterine cancer	2.08e-05	0.000354	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CDKN2B—uterine cancer	2.03e-05	0.000345	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—AKT1—uterine cancer	2.01e-05	0.000342	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—AKR1C3—uterine cancer	1.97e-05	0.000335	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.94e-05	0.00033	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—AKT1—uterine cancer	1.9e-05	0.000324	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—STK11—uterine cancer	1.89e-05	0.000322	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYP19A1—uterine cancer	1.89e-05	0.000322	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—RRM2—uterine cancer	1.86e-05	0.000317	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—SMAD3—uterine cancer	1.85e-05	0.000315	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—DCN—uterine cancer	1.81e-05	0.000308	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—MTHFR—uterine cancer	1.79e-05	0.000305	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.78e-05	0.000302	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PTEN—uterine cancer	1.77e-05	0.000301	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.77e-05	0.000301	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FGFR2—uterine cancer	1.76e-05	0.0003	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.7e-05	0.00029	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MTHFR—uterine cancer	1.7e-05	0.000289	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.69e-05	0.000288	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—EP300—uterine cancer	1.69e-05	0.000287	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.61e-05	0.000274	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.58e-05	0.000269	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—STK11—uterine cancer	1.53e-05	0.000261	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP19A1—uterine cancer	1.53e-05	0.000261	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—EP300—uterine cancer	1.51e-05	0.000256	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PTEN—uterine cancer	1.5e-05	0.000256	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.44e-05	0.000245	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—EP300—uterine cancer	1.44e-05	0.000244	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—VEGFA—uterine cancer	1.43e-05	0.000243	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—MTHFR—uterine cancer	1.42e-05	0.000242	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—NRAS—uterine cancer	1.41e-05	0.00024	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.37e-05	0.000233	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—STK11—uterine cancer	1.25e-05	0.000213	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.25e-05	0.000213	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.25e-05	0.000213	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CA—uterine cancer	1.25e-05	0.000213	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTEN—uterine cancer	1.22e-05	0.000208	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTEN—uterine cancer	1.22e-05	0.000208	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—KRAS—uterine cancer	1.21e-05	0.000206	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.18e-05	0.0002	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—EP300—uterine cancer	1.17e-05	0.000199	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—EP300—uterine cancer	1.17e-05	0.000199	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—MTHFR—uterine cancer	1.15e-05	0.000196	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.12e-05	0.000191	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CA—uterine cancer	1.11e-05	0.00019	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—ERBB2—uterine cancer	1.11e-05	0.000189	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TP53—uterine cancer	1.08e-05	0.000183	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CA—uterine cancer	1.06e-05	0.000181	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—HRAS—uterine cancer	1.03e-05	0.000175	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CDKN1B—uterine cancer	1.03e-05	0.000175	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—AKT1—uterine cancer	1.02e-05	0.000174	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.01e-05	0.000173	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PTEN—uterine cancer	9.97e-06	0.00017	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CTNNB1—uterine cancer	9.7e-06	0.000165	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—EP300—uterine cancer	9.51e-06	0.000162	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PTEN—uterine cancer	9.45e-06	0.000161	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—MTHFR—uterine cancer	9.42e-06	0.00016	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—AKT1—uterine cancer	9.1e-06	0.000155	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EP300—uterine cancer	9.01e-06	0.000153	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—AKT1—uterine cancer	8.67e-06	0.000148	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CA—uterine cancer	8.63e-06	0.000147	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CA—uterine cancer	8.63e-06	0.000147	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NRAS—uterine cancer	8.43e-06	0.000143	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.3e-06	0.000141	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PTEN—uterine cancer	7.91e-06	0.000135	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—EP300—uterine cancer	7.55e-06	0.000128	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—KRAS—uterine cancer	7.26e-06	0.000124	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—AKT1—uterine cancer	7.05e-06	0.00012	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—AKT1—uterine cancer	7.05e-06	0.00012	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CA—uterine cancer	7.03e-06	0.00012	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CA—uterine cancer	6.67e-06	0.000113	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTEN—uterine cancer	6.4e-06	0.000109	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HRAS—uterine cancer	6.17e-06	0.000105	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—EP300—uterine cancer	6.11e-06	0.000104	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—AKT1—uterine cancer	5.75e-06	9.78e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CA—uterine cancer	5.58e-06	9.5e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—AKT1—uterine cancer	5.45e-06	9.27e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTEN—uterine cancer	5.24e-06	8.92e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—EP300—uterine cancer	5e-06	8.51e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—AKT1—uterine cancer	4.56e-06	7.76e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CA—uterine cancer	4.52e-06	7.69e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CA—uterine cancer	3.7e-06	6.29e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—AKT1—uterine cancer	3.69e-06	6.28e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AKT1—uterine cancer	3.02e-06	5.14e-05	CbGpPWpGaD
